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ABSTRACT 
Urinary tract infections are more common, more severe, and carry worse 
out comes in patients with type 2 diabetes mellitus. They are more often 
caused by resistant pathogens. The management of UTI in diabetes 
patients is very difficult. The patients are undergoing for antibiotic 
treatment for this issue in every occasion. In Siddha system, the diabetes 
has been successfully treated with traditional Siddha preparations which 
are poly herbal, herbo-mineral and metallic formulations. Most of the 
Siddha anti-diabetic preparations are possessing anti bacterial effect 
along with its anti-diabetic effect. So the management of urinary tract 
infections in diabetic patients is very easy. Naaval Kottai Mathirai is one 
among the anti-diabetic Siddha herbal preparation which is prepared 
from the seeds of Syzygium cumini (L.) skeels and Aristolochia 
bracteolata Lam. leaf juice. An attempt has been made to screen the 
antibacterial effect of NKM against the selected pathogens which are 
commonly responsible for UTI particularly in diabetes by disc diffusion 
method. The result of this study is really appreciable. The result of this 
study showed the marked anti bacterial effect against Escherichia coli 
15mm, Staphylococcus aureus 17mm, Bacillus subtilis 14mm, Klebsiella 
pneumonia 12mm, Pseudomonas aeruginosa 12mm and Enterococcus 
faecalis 11mm. Finally this study concluded that, the drug NKM can be 
used for diabetes and UTI particularly in diabetic patients. Further 
studies are needed to explore the novel antibacterial bioactive molecules. 
 
INTRODUCTION 
Diabetes mellitus is a major risk factor for 
urinary tract infections (UTIs) and is also associated 
with increased risk of certain complicated UTIs 
such as emphysematous pyelonephritis (EPN), 
emphysematous pyelitis (EP), emphysematous 
cystitis (EC), xanthogranulomatous pyelonephritis 
(XGP), renal/ perirenal abscess, and renal papillary 
necrosis (RPN). Such conditions are potentially life 
threatening and require prompt evaluation and 
management. The increased frequency of UTIs in 
diabetic patients is likely due to several 
mechanisms including the presence of glycosuria, 
neutrophil dysfunction and increased adherence of 
the bacteria to uroepithelial cells. Factors that 
increase the risk of UTIs in diabetes include age, 
metabolic control, diabetic nephropathy, autonomic 
neuropathy and vascular complications.[1]  
 Emphysematous complications in the 
kidney or the bladder are likely to be due to the 
presence of organisms that rapidly ferment glucose 
and produce carbon dioxide. Impaired transport of 
metabolic end products due to impaired tissue 
perfusion in diabetes may also contribute.[2] 
Escherichia coli, is the most common pathogens 
isolated from urine of diabetic patients with UTI. 
Other organisms includes Enterobacteriaceae such 
as Klebsiella spp., Proteus spp., Enterobacter spp., 
and Enterococci.[3] Patients with diabetes are more 
prone to have resistant pathogens as the cause of 
their UTI, including extended-spectrum β-
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lactamase-positive Enterobacteriaceae.[4] Over 90% 
of patients with diabetes mellitus has 
emphysematous pyelonephritis[5] and 67% has 
emphysematous cystitis.[6]  
 In diabetic patients, it is generally accepted 
that infections are frequent causes of morbidity and 
mortality.[7] Immunologic defects contribute to the 
increased risk for infection: impaired neutrophil 
function, low levels of prostaglandin E, 
thromboxane B2, leukotriene B4, decreased T cell-
mediated immune response, etc.[7-9] Other 
conditions such as incomplete bladder emptying 
due to autonomic neuropathy and high glucose 
concentration in the urine allow urinary 
colonization by microorganisms.[9,10] There is 
evidence that patients with diabetes have an 
increased risk of asymptomatic bacteriuria and 
urinary tract infections (UTIs)[8,9]. UTIs are the most 
common bacterial infections in diabetic patients.[11] 
Moreover it is important to recognize and to treat 
UTIs in diabetic patients because of their possibly 
severe complications, including bacteriuria, renal 
abscess and renal papillary necrosis.[9, 10, 12] To treat 
UTI in diabetics is difficult because of its frequent 
recurrence, involving greater costs for the medical 
system and for the patient himself. 
UTI is correlated with the symptoms of 
Moothira Kiricharam in Siddha system of medicine 
which is more common in diabetes. Untreated 
Kiricharam may leads to severe complication. In 
diabetes the management of Kiricharam is more 
difficult. The patients are undergoing for antibiotic 
treatment for this issue in every occasion. 
Nowadays most of the practitioners are prescribing 
two types of medicines for the management of UTI 
in diabetes patient in which one for diabetes and 
another one for UTI. It could not be affordable for 
all patients. In Siddha system of medicine, most of 
the polyherbal anti-diabetic formulations are 
having anti-microbial effect along with anti- 
diabetic effect. It may help to treat the UTI with 
diabetes in easy manner because it possess both 
anti microbial and anti diabetic effect. Naaval Kottai 
Mathirai is herbal anti-diabetic Siddha preparation 
prepared from the seeds of Syzygium cumini (L.) 
skeels and Aristolochia bracteolata Lam. which is 
used for the management of diabetes. The present 
study is aimed to screen the anti bacterial effect of 
anti-diabetic Siddha herbal preparation Naaval 
Kottai Mathirai against the selected human 
pathogens.  
 
 
 
MATERIALS AND METHODS 
Plant material and Naaval Kottai Mathirai 
preparation 
The seeds of Syzygium cumini (L.) skeels 
(Figure:1) and Aristolochia bracteolata Lam. 
(Figure:2) were collected from Seeganendal village, 
Pudukkottai district, Tamilnadu and duly 
authenticated by Prof. P. Jayaraman, Director, Plant 
Anatomy Research Centre, Chennai-45. The 
authentication number is PARC/2016/3255 and 
3256. The collected seeds of S.cumini were 
powdered and grounded by adding the leaf juice of 
A. bracteolata until its waxy consistency and made 
into 500mg pills (Pattani size). 
  
Figure: 1. Seeds of Syzygium cumini 
 
 Figure: 2. Aristolochia bracteolata 
 
Figure: 3. Naaval Kottai Mathirai 
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Anti-bacterial Activity 
  The anti- bacterial activity of the sample 
NKM was carried out by disc diffusion method. The 
concentrations of the test compounds were used at 
the concentration of 100,200,300µg. The target 
microorganisms were cultured in Muller-Hinton 
broth (MHB). After 24 h the suspensions were 
adjusted to standard sub culture dilution. Then the 
diluted bacterial stains were cultured in petri 
dishes containing Muller-Hinton Agar (MHA) 
medium. Disc made of Whatman No.1, diameter 
6mm was pre- sterilized and was maintained in 
aseptic chamber. Each concentration was injected 
to the sterile disc papers. Then the prepared discs 
were placed on the culture medium. Standard drug 
streptomycin (20µg) was used as a positive 
reference standard to determine the sensitivity of 
each microbial species tested. Then the inoculated 
plates were incubated for 24h at 37˚C. The diameter 
of the clear zone around the disc was measured and 
expressed millimetres as its anti-microbial 
property. 
RESULTS 
Table 1: Anti- bacterial Effect of Naaval Kottai Mathirai 
Name of the 
Microorganism 
Anti-bacterial effect of Naaval Kottai 
Mathirai (Zone of Inhibition in mm) 
Streptomycin  
100µg/ml 200µg/ml 300µg/ml 20µg/ml 
Bacillus subtilis 9 11 14 23 
Staphylococcus aureus 11 13 17 18 
Enterococcus faecalis 8 10 11 18 
Pseudomonas aeruginosa 8 10 12 14 
Escherichia coli 10 11 15 25 
Klebsiella pneumonia 10 11 12 19 
Anti Bacterial effect of Naaval Kottai Mathirai 
     
Bacillus subtilis    Staphylococcus aureus 
    
Enterococcus faecalis    Escherichia coli 
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Pseudomonas aeruginosa    Klebsiella pneumonia 
DISCUSSION 
Naaval Kottai Mathirai has been used for 
the management of diabetes by Siddha physicians 
and traditional practitioner. The urinary tract 
infections are more common, more severe, and 
carry worse outcomes in patients with type 2 
diabetes mellitus. They are more often caused by 
resistant pathogens.  
 The management of UTI in diabetes patients 
is very difficult. The patients are undergoing for 
antibiotic treatment for this issue in every occasion. 
The drug Naaval Kottai Mathirai has been 
performed for anti bacterial effect against the 
selected human pathogens.  
 The result of this study showed the 
significant anti bacterial effect of maximum zone of 
inhibition were obtained against Escherichia coli 
15mm, Staphylococcus aureu 17mm, Bacillus 
subtilis 14mm, Klebsiella pneumonia 12mm, 
Pseudomonas aeruginosa 12mm and Enterococcus 
faecalis 11mm when compared to the standard, 
Streptomycin (20µg) which exhibited anti bacterial 
effect by the measurement of Zone of inhibition 
25mm, 18mm, 23mm, 19mm, 14mm and 18mm 
respectively. From this study result the drug NKM 
can be used for Urinary Tract Infections of Diabetes 
patients. 
In Siddha system, taste plays a major role in 
selection of drugs, drug combination and treatment. 
According to Siddha Taste Theory, the bitter taste 
helps to destroy the micro-organism, to reduce the 
blood sugar and eliminate the toxins. Astringent 
taste acts as a blood purifier and helps to treat 
wounds. In this view, the ingredients of NKM, seeds 
of Syzygium Cumini possess strong astringent taste 
and Aristolochia bracteolata has bitter taste.[13] So 
as per Siddha fundamental taste theory, this 
formulation NKM is effective on UTI of diabetic 
patients. 
 
CONCLUSION 
 From the in depth of Siddha fundamental 
taste theory and the result of anti-bacterial activity 
this study concluded that, the Siddha anti-diabetic 
herbal preparation Naaval Kottai Mathirai can be 
used as a drug of choice in the management of 
Diabetes with Urinary Tract Infection.  
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